Samson Clinical Begins Phase III Trial for Sublingual Minoxidil in Treating Male Pattern Baldness Samson Clinical has announced the initiation of its Phase III trial for sublingual minoxidil, targeting male pattern hair loss. This study aims to assess the treatment’s efficacy and safety.

Samson Clinical Begins Phase III Trial for Sublingual Minoxidil in Treating Male Pattern Baldness #Australia #Melbourne #hair_loss_treatment #Minoxidil_Trial #Samson_Clinical